Verdict: KEEP at benchmark 2.37%

No thesis for removal. Pristine execution across every metric, tariff beneficiary vs peers, no idiosyncratic catalyst for underperformance in the 15-week window. Low QQQ beta (0.28) is a portfolio-level concern, not a stock-specific removal signal. Market consensus is correct — no mispricing identified. 37 analysts, $437B cap, zero information asymmetry.

LR 0.8 (supports KEEP). Evidence uniformly against removal. No bear thesis survives scrutiny.


Factor Profile (worldview regression, 251d daily)

MetricValueAssessment
beta QQQ0.28Consumer staple in tech index
beta SPY0.36Low market sensitivity
beta XLP0.86Structurally a staples stock
beta MTUM0.02No momentum exposure
Idio variance87.2%Clean (>75% target)
alpha (annualized)+1.3%t=0.10, statistically zero
Idio vol18.9%Low
R-squared vs QQQ9.9%Moves independently of index

Rolling 60d beta to QQQ declined from 0.42 (Jul 2025) to 0.00 (Feb 2026). This stock increasingly decouples from the tech-growth index.


Financial Deep Dive (10-Q filed 2026-03-11, transcript 2026-03-05)

Income Statement (Q2 FY2026, 12 weeks ended Feb 15)

LineQ2 FY2026Q2 FY2025YoY
Net sales$68,242M$62,530M+9.1%
Membership fees$1,355M$1,193M+13.6%
Total revenue$69,597M$63,723M+9.2%
Merch costs$60,719M$55,744M+8.9%
SG&A$6,272M$5,663M+10.8%
Operating income$2,606M$2,316M+12.5%
Net income$2,035M$1,788M+13.8%
EPS (diluted)$4.58$4.02+13.9%

Margin waterfall:

  • Gross margin: 11.02% (+17 bps YoY; +11 bps ex gas)
  • Core-on-core gross margin: +22 bps (broad-based: nonfood, food & sundries, fresh all higher)
  • SG&A rate: 9.19% (+13 bps; +8 bps ex gas). Ops component flat ex gas — productivity offset wage investments + extended hours. Central +3-4 bps. Liability reserve one-time: 6 bps. Underlying SG&A +2 bps ex gas. Clean.
  • Operating margin: 3.82% (+12 bps)
  • Tax rate: 25.2% vs 26.2% (100 bps benefit, ≈1% EPS tailwind)

Segment Margins (Q2)

SegmentRevenueOp IncomeMarginYoY
US$49,931M$1,635M3.27%+1 bp
Canada$9,291M$476M5.12%+26 bps
Other Intl$10,375M$495M4.77%+35 bps

US margin flat. All expansion from international + FX. If dollar strengthens, this tailwind reverses. Not a risk for filtration (affects absolute return, not QQQ-relative).

Balance Sheet

ItemFeb 15, 2026Aug 31, 2025Change
Cash$17,383M$14,161M+$3,222M
Inventory$18,991M$18,116M+$875M (+4.8%)
Accounts payable$20,647M$19,783M+$864M
Deferred membership$3,126M$2,854M+$272M (+9.5%)
Long-term debt$5,688M$5,713M-$25M
Total equity$32,087M$29,164M+$2,923M

Net working capital in merchandise: Inventory minus AP = negative $1.66B. Costco sells before it pays. Model intact. Inventory days ≈24 vs ≈25 last year — improving turnover despite inventory build. H1 FCF ≈$4.9B.


Comp Sales Trend

PeriodAdj CompTrafficAdj Ticket
Q1 FY2026+7.2%+3.3%+3.7%
Q2 FY2026+6.7%+3.1%+3.5%
Feb (4 wks)+7.0%+3.0%+3.9%

Remarkably stable. Management: "very consistent in that 6-7% range." February US traffic slightly soft due to Northeast weather (55 warehouses closed a full day), but total results unaffected. Digital comp +22.6%.


Membership Deep Dive

MetricQ2 FY2026YoY
Total paid members82.1M+4.8%
Executive members40.4M+9.5%
US/Canada renewal92.1%-10 bps QoQ
Worldwide renewal89.7%flat QoQ
Executive penetration75.8% of sales--
Membership income (organic ex fee/FX)--+7.5%

Membership growth deceleration: 4.8% vs ≈5% historical. CFO attributes to cycling strong prior-year sign-ups and fewer new market openings. Not structural. Executive upgrades +9.5% show depth of engagement.

Renewal rate decline slowing: -40 bps (Q4 FY2025) to -30 bps to -10 bps (Q2 FY2026). CFO: "may slow a few more quarters" but digital retention programs working. Driver is online member mix renewing at lower rates than warehouse sign-ups. CFO flagged explicitly in Q4 FY2025: "we do think we'll see a few more quarters of a similar type of impact." Worldwide rate held flat at 89.7%.

Fee Increase Lapping — The Math

The September 2024 fee increase ($5 Gold Star/Business, $10 Executive) is still contributing to YoY growth because memberships renew on a rolling annual basis.

QuarterTotal Fee GrowthOrganic (ex fee/FX)Fee Increase Contribution
Q3 FY2025+10.4%≈5.8%≈4.6% (first partial quarter)
Q4 FY2025+14.0%≈7%≈7% ("less than half")
Q1 FY2026+14.0%7.3%≈6.7% ("little less than half")
Q2 FY2026+13.6%7.5%≈6.1%
Q3 FY2026E≈11.5%≈7.5%≈4% (diminishing)
Q4 FY2026E≈9.5%≈7.5%≈2%
Q1 FY2027E≈8%≈8%≈0% (fully lapped)

This creates a "deceleration" headline in Q3 and Q4, but the dollar impact is immaterial: delta between 13.6% and 11.5% on $1.24B base = $26M revenue, ≈$0.04/share after tax. At 48x, that's $2 of stock price. Noise.

The CFO pre-disclosed the 7.5% organic figure on the Q2 call. Every analyst covering COST knows the lapping schedule. Probability of a "dumb money sells the headline" reaction: 15-20%. Even then, 2-3% stock move on 2.37% weight = 5-7 bps basket impact. Not actionable.


Tariff Exposure

CEO Vachris (transcript, Mar 5, 2026):

  • "Future impact of tariffs remains extremely fluid as recently eliminated IEEPA tariffs replaced with new global tariffs for at least next 150 days"
  • Mitigation: (1) country switching, (2) consolidated global buying, (3) Kirkland Signature lean-in (≈30% of sales, max supply chain control), (4) domestic sourcing
  • "We believe our expertise in buying and our limited SKU count model puts us in a position to manage this as well as anyone"
  • Already lowering prices where tariffs reduced (textiles, bedding, cookware)
  • ≈70% revenue from domestic categories (food, pharmacy, gas)
  • IEEPA refund process "not yet clear"

Cross-ticker: Value retailers confirmed tariff beneficiaries (TJX CEO: tariff confusion "indirectly good" for off-price/value).

Low single-digit inflation in nonfoods (≈30% of sales) already flowing through. Margin absorbed. CFO: "we look at it as being up by 5 basis points in the quarter and being able to achieve that growth when we were also lowering prices for members and managing the impact of tariffs."


What the Market Is Pricing

Earnings Trajectory

MetricValue
Forward P/E (NTM)43.85x
Implied NTM EPS≈$22.43
FY2025 EPS$18.21
FY2026 H1 (actual)$9.08 ($4.50 + $4.58)
Q3 FY2026 est$4.95
Implied sustainable EPS growth12-13%

The market is pricing continuation of COST's 10-year EPS CAGR (≈13%), built from: comp sales 6-7% (management-guided), unit growth ≈3% (28-30 new warehouses on ≈930 base), modest operating leverage (≈1-2%), no buyback contribution. This is not heroic — it's exactly what COST has delivered.

PEG ratio: 44x / 12% = 3.7x. S&P 500 PEG: ≈2.1x. COST premium: 1.76x market PEG. Historical COST PEG range (5Y): 2.5x to 4.5x. Current = mid-range.

Sell-Side Consensus

SourceTargetImplied Return
Median (37 analysts)$1,100+12%
JP Morgan (OW)$1,060+8%
BMO (OP, outlier bull)$1,315+34%
DA Davidson (Neutral)$1,000+2%
Truist (Hold)$977-1%

23 Buy/Strong Buy, 12 Hold, 2 Sell. 62% bullish, 5% bearish. The debate is exclusively about valuation, not fundamentals. The bears (Truist, DA Davidson) say "fairly valued here." The bulls roll forward 12% EPS growth at the current premium multiple. Sell-side isn't calling for multiple expansion — this is a "hold for the compounder" thesis.

Beat cadence: 4/4 quarters, average +2.1%. Reliable but not blowout — no surprise catalyst.

Options Market — More Cautious Than Sell-Side

May 15 (47 DTE, pre-earnings):

  • P/C OI: 1.27. P/C Volume: 3.33. Bearish positioning and flow
  • Max pain: $950 (3.4% below current)
  • Unusual: $855 puts saw 900 contracts vs 22 OI (40.9x ratio). -13% strike protection
  • Put skew: +19.3% OTM vs ATM — steep, paying up for downside

July 17 (110 DTE, spans full 15-week window + May 28 earnings):

  • P/C OI: 1.82. Nearly 2:1 puts to calls
  • Max pain: $980 (flat)
  • Call IV elevated +4.3% above puts (unusual — short sellers hedging upside)
  • IV: 28.6% vs 19.9% realized = 8.7% vol risk premium

Implied distribution through July 17:

  • Expected 1-sigma move: +/-15.7%. Range: ≈$829 to ≈$1,138
  • Earnings day implied move: ≈5.9% (consistent with 3-7% historical)
  • Put skew steeper for May than July — market hedging a pre-earnings event (March comps Apr 8 or tariff escalation), not the earnings themselves

Key divergence: Sell-side says +12%. Options max pain says flat. The money is positioned for flat to down, with tail hedges in place for -13%. Options are more relevant for our 15-week window.

Short interest 1.4% of float, 3.4 days to cover. Nobody is actually short.


Mispricing Assessment: None

Stress-tested five potential mispricings. None survive.

1. Fee lapping deceleration. Dollar impact: $0.04/share. Price impact at 48x: $2. CFO pre-disclosed 7.5% organic. Every analyst heard it. Not mispriced.

2. Renewal rate structural decline. Trajectory decelerating (-40 bps to -10 bps/Q). CFO explicitly guided it. Online member mix stabilizing. Not hidden, not accelerating.

3. Valuation premium. PEG 3.7x is mid-range of 5-year history (2.5x-4.5x). No catalyst for compression in window absent a fundamental miss.

4. Tariff second-order effects. Consensus correctly identifies COST as relative winner. CEO's actions match words (cutting prices on reduced-tariff items). Cross-ticker confirms.

5. Options put-heavy positioning. Institutional hedging on a $437B defensive name during trade war = standard portfolio insurance, not directional conviction. $4.4M in $855 put premium vs $2B+ daily traded value.

Counterparty test: If we short COST in the basket, the counterparty is every informed participant — 37 analysts, 92% institutional ownership, monthly comp data, quarterly guided. Information asymmetry = zero. Edge = zero.


Bear Case Audit

RiskSeverityProbabilityBasket Impact
Beta mismatch (QQQ rally, COST drags)Medium≈55% (QQQ direction)-17 bps at 2.37% weight
Fee lapping headline selloffLow15-20%5-7 bps
Tariff escalation on nonfoodsLow20-30%Margins absorb
Comp deceleration below 5% adjLow15%Feb was +7%, trend stable
Valuation compressionLow15%Requires fundamental miss
Renewal rate decline acceleratesVery Low5%10 bps/Q, slowing

No bear thesis survives scrutiny. Every risk is either low-probability, already priced, or a portfolio-level beta concern (not idiosyncratic).


Filtration Analysis

At 2.37% weight with beta QQQ = 0.28:

QQQ ScenarioCOST ExpectedFiltration alpha if Removed
QQQ +10%COST +2.8%+17 bps (drag removed)
QQQ flatCOST +0.3%-1 bp
QQQ -10%COST -2.2%-18 bps (cushion removed)

Removing COST = directional bet on QQQ rally with zero IC. The counterparty is the index methodology.

Why Not Remove

  1. No idiosyncratic weakness. 9% sales growth, 7% adj comps, 14% EPS growth, 92% renewal, $17.4B cash, improving inventory turnover, management proactively managing tariffs.

  2. Beta mismatch is not removal. 13 of 42 survivors have QQQ beta below 0.5 totaling 11.0% of selectable weight. Removing all low-beta names is a market-timing bet with zero IC.

  3. US margin flat is investment, not deterioration. Absorbing wage investments and extended hours, offset by productivity.

  4. SG&A one-time. 6 bps from liability reserve charge. Underlying +2 bps.

  5. Membership decel is minor. 4.8% vs ≈5% historical. Not structural.

  6. Consensus is correct. No information asymmetry. No crowd to fade. No mispricing to exploit.


Calendar

DateEventAction
Apr 8March comps (4 weeks, after market)If adj comps below 5%, investigate
May 28Q3 FY2026 earnings (est $4.95 EPS)If miss + guide-down, reconsider
Jul 10Basket ends--

Sources

  • 10-Q filed 2026-03-11 (balance sheet, income statement, segment data, litigation, risk factors)
  • 8-K filed 2026-03-05 (Q2 supplemental data, margin waterfall)
  • Q2 FY2026 earnings transcript 2026-03-05 (Millerchip + Vachris: tariff commentary, membership dynamics, margin discussion, fee lapping disclosure)
  • Q4 FY2025 earnings transcript 2025-09-25 (renewal rate guidance, online member mix)
  • yfinance ticker/options data 2026-03-28 (valuation, insiders, analysts, options positioning)
  • Worldview evidence database (7 items)